WEBVTT

00:00:00.000 --> 00:00:05.833
Rick Doblin, Ph.D. MAPS Executive Director
Paving the Way From Banned Drug to Legal Medicine

00:00:05.833 --> 00:00:10.437
Psychedelics have been used by tens of millions, hundreds of millions of people

00:00:10.437 --> 00:00:13.143
so we know the risks of psychedelics.

00:00:13.143 --> 00:00:16.642
We have hundreds of millions of dollars already spent by the governments on the risks

00:00:16.642 --> 00:00:20.703
and we don't have to do that research again. It's in the public domain.

00:00:20.703 --> 00:00:28.499
For roughly $10 million focused very narrowly on an ever expanding series of studies

00:00:28.499 --> 00:00:32.945
looking at safety of, and efficacy of, psychedelics in specific patient populations,

00:00:32.945 --> 00:00:41.188
it's a reasonable goal. $10 million is not out of reach, because first of it's like $10 million over 10 years.

00:00:41.188 --> 00:00:47.119
It's not like you need to write a check all at once. So that the goal for a non-profit organisation

00:00:47.119 --> 00:00:54.785
through donations rather than investments to raise enough money to do the research, it's, it's possible.

00:00:55.741 --> 00:00:59.900
Interview courtesy of "From Neurons to Nirvana: The Great Medicines" by Oliver Hockenhull. Film to be released later in 2012.

00:01:02.223 --> 00:01:06.283
The Multidisciplinary Association For Psychedelic Studies
maps.org